Quality of life in patients with chronic migraine: relation to migraine severity, depression and sleep disturbances

Background. Headache chronification is associated with significant negative impact on health-related quality of life (QOL). Patients with chronic migraine have decreased QOL and increased headache-related disability, than do patients with episodic migraine. The degree to which these outcomes are connected to disease severity, to the pattern of sociodemographic and comorbidity profiles, such as depression, anxiety and sleep disturbances, are unclear.

Objective. To assess QOL and to identify predictors of its reduction in patients with chronic migraine.

Materials and methods. 160 outpatients with migraine were recruited from a headache center and completed self-report questionnaires including the Headache Impact Test 6 (HIT-6) to assess QOL, Migraine Disability Assessment (MIDAS), Beck depression inventory, Spilberger–Khanin anxiety questionnaire, and Subjective sleep characteristics assessment questionnaire (SSCA). We used multiple regression analyses to obtain QОL predictors and path analysis model to identify relationship between the variables.

Results. Patients with chronic migraine (n = 90) had very poor QOL, more severe migraine and comorbid disorders, than did patients with episodic migraine (n = 70). The strongest predictor of the QOL score was the Beck depression inventory score (β = 0.383; p < 0.001) and SSCA questionnaire score (β = –0.341; p < 0.001); followed by the MIDAS score (β = 0.301; p < 0.001), female gender (β = 0.198; p < 0.001), headache intensity (β = 0.173; p < 0.001), attack duration (β = 0.169; p = 0.001), headache frequency (β = 0.150; p = 0.015). Scores of Beck depression inventory, SSCA questionnaire, MIDAS, and headache features (frequency, duration, intensity) had a direct effect on the QOL.

Conclusions. Depression and sleep disturbance appear to impair QOL as strong as the severe clinical manifestations of migraine.

1. Natoli J. L., Manack A., Dean B. et al. Global prevalence of chronic migraine: а systematic review. Cephalalgia 2010;30(5):599–609. DOI: 10.1111/j.1468-2982.2009.01941.x. PMID: 19614702.

2. Steiner T. J., Stovner L. J., Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016;17(1):104. DOI: 10.1186/s10194-016-0699-5. PMID: 27844455.

3. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386(9995):743–800. DOI: 10.1016/S0140-6736(15)60692-4. PMID: 26063472.

4. Артеменко А. Р., Куренков А. Л., Беломестова К. В. Классификация, диагностика и лечение хронической мигрени: обзор новых данных. Журнал неврологии и психиатрии им. С. С. Корсакова 2013;(11):91–6. [Artemenko A. R., Kurenkov A. L., Belomestova K. V. Classification, diagnosis and treatment of chronic migraine: review of new data. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2013;113(11):91–6. (In Russ.)]. PMID: 24429956.

5. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629–808. DOI: 10.1177/0333102413485658. PMID: 23771276.

6. Stewart W. F., Wood G. C., Manack A. et al. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med 2010;52(1):8–14. DOI: 10.1097/JOM.0b013e3181c1dc56. PMID: 20042889.

7. Bloudek L. M., Stokes M., Buse D. C. et al. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 2012;13(5):361–78. DOI: 10.1007/s10194-012-0460-7. PMID: 22644214.

8. Ayzenberg I., Katsarava Z., Sborowski A. et al. The prevalence of primary headache disorder in Russia: a countrywide survey. Cephalalgia 2012;32(5):373–81. DOI: 10.1177/0333102412438977. PMID: 22395797.

9. Глембоцкая Г. Т., Козуб О. В. Фармако экономическая оценка «бремени» мигрени в Российской Федерации. Клиническая фармакология и терапия. 2013;22(2):83–6. [Glembotskaya G. T., Kozub O. V. Pharmacyeconomical estimation “burden” of migraine in

10. Russian Federation. Klinicheskaya pharmakologia i terapiya = Clinical Pharmacology and Therapy 2013;22(2):83–6. (In Russ.)].

11. Dahlof C. G., Dimenas E. Migraine patients experience poorer subjective well- being/quality of life even between attacks. Cephalalgia 1995;15(1):31–6. DOI: 10.1046/j.468-2982.1995.1501031.x. PMID: 7758095.

12. Stuginski-Barbosa J., Dach F., Bigal M., Speciali J. G. Chronic pain and depression in the quality of life of women with migraine – a controlled study. Headache 2012;52(3):400–8. DOI: 10.1111/j.1526-4610.2012.02095.x. PMID: 22332812.

13. Осипова В. В., Табеева Г. Р. Первичные головные боли: диагностика, клиника, терапия. М.: ООО «Издательство «Медицинское информационное агентство», 2014. 336 с. [Osipova V. V., Tabeeva G. R. Primary headaches: diagnostics, clinical picture, therapy. Moscow: OOO «Izdatel’stvo «Meditsinskoe informatsionnoe agentstvo”, 2014. 336 p. (In Russ.)].

14. Закирова Э. Н., Воеводин В. А., Ахмадеева Л. Р., Кутлубаев М. А. Качество жизни больных с различными головными болями. Успехи современного естествознания 2004;(12):39–41. [Zakirova E. N., Voevodin V. A., Akhmadeeva L. R., Kutlubaev M. A. Quality of life patients with different headaches. Uspekhi sovremennogo estestvoznaniya = Progress of Modern Natural Science 2004;(12):39–41. (In Russ.)].

15. Шестаков В. В., Старикова Н. Л. Качество жизни при мигрени в сопоставлении с клиническими характеристиками заболевания и личностными особенностями пациентов. Неврологический журнал 2009;(3):29–33. [Shestakov V. V., Starikova N. L. Quality of life in migraine in comparison with clinical characteristics of disease and personality characteristics of patients. Nevrologicheskiy zhurnal = Neurological Journal 2009;(3):29–33. (In Russ.)].

16. Lipton R. B., Hamelsky S. W., Kolodner K. B. et al. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000;55(5):629–35. PMID: 10980724.

17. Buse D. C., Manack A., Serrano D. et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010;81(4):428–32. DOI: 10.1136/jnnp.2009.192492. PMID: 20164501.

18. Blumenfeld A. M., Varon S. F., Wilcox T. K. et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011;31(3):301–15. DOI: 10.1177/0333102410381145. PMID: 20813784.

19. Артеменко А. Р., Куренков А. Л., Антипова О. С. Диагностика и лечение хронической мигрени. М.: Горячая линия – Телеком, 2014. 206 с. [Artemenko A. R., Kurenkov A. L., Antipova O. S. Diagnostics and treatment of chronic migraine. Moscow: Goryachaya liniya – Telekom, 2014. 206 p. (In Russ.)].

20. Serafini G., Pompili M., Innamorati M. et al. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci 2012;16(10):1389–98. PMID: 23104655.

21. Антипова О. С. Расстройства аффективного спектра у пациентов с хронической мигренью. В кн.: Диагностика и лечение хронической мигрени. Под ред. А. Р. Артеменко, А. Л. Куренкова, О. С. Антиповой М.: Горячая линия – Телеком, 2014. С. 183– 204. [Antipova O. S. Affective disorders in patient with chronic migraine. In book: Diagnostics and treatment of chronic migraine. Eds. A. R. Artemenko, A. L. Kurenkov, O. S. Antipova. Moscow: Goryachaya liniya – Telekom, 2014. Рр. 183–204. (In Russ.)].

22. Canuet L., Ishii R., Fernandez- Concepcion O. et al. Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: comparison with episodic migraine. Psychiatry Clin Neurosci 2008;62(6):738–40. DOI: 10.1111/j.1440- 1819.2008.01867.x. PMID: 19068012.

23. Данилов А. Б. Кто больше страдает при мигрени: мужчины или женщины? Терапевт 2006;(10):35–8. [Danilov A. B. Who is more affected by migraine headaches: men or women? Terapevt = Therapeutist 2006;(10):35–8. (In Russ.)].

24. Rendas-Baum R., Yang M., Varon S. F. et al. Validation of the Headache Impact Test (HIT- 6) in patients with chronic migraine. Health Quality Life Outcomes 2014;12:117. DOI: 10.1186/s12955-014-0117-0. PMID: 25080874.

25. Stewart W. F., Lipton R. B., Whyte J. et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999;53(5):988–94. PMID: 10496257.

26. Beck A. T., Steer R. A., Brown G. K. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation, 1996.

27. Исследование тревожности (Ч. Д. Спилбергер, адаптация Ю. Л. Ханин). В кн.: Диагностика эмоционально-нравственного развития. Ред. и сост. И. Б. Дерманова. СПб., 2002. С. 124–126. [Investigation of anxiety (Ch. D. Spielberger, adaptation Yu. L. Khanin). In book: Diagnostics of emotional-moral development. Ed. and comp. by I. B. Dermanovа. Saint Petersburg, 2002. Pp. 124–126. (In Russ.)].

28. Левин Я. И., Елигулашвили Т. С., Посохов С. И. и др. Фармакотерапия инсомний: роль имована. В кн.: Расстройства сна. Под ред. Ю. А. Александровского, А. М. Вейна. СПб.: Медицинское информационное агентство, 1995. C. 56–61. [Levin Ya. I., Eligulashvili T. S., Posokhov S. I. et al. Pharmacotherapy of insomnias: role of Imovane. In book: Sleep disorders. Eds. Yu. A. Aleksandrovskiy, A. M. Veyn. Saint Petersburg: Meditsinskoe informatsionnoe agentstvo, 1995. Pp. 56–61. (In Russ.)].

29. Dodick D. W., Turkel C. C., DeGryse R.E. et al. Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50(6):921–36. DOI: 10.1111/j.1526-4610.2010.01678.x. PMID: 20487038.

30. Wang S. J., Wang P. J., Fuh J. L. et al. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan. Cephalalgia 2013;33(3):171–81. DOI: 10.1177/0333102412468668. PMID: 23203506.

31. Kim S. Y., Park S. P. The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain 2014;15:68. DOI: 10.1186/1129-2377-15-68. PMID: 25278151.

32. Амелин А. В., Игнатов Ю. Д., Скоромец А. А., Соколов А. Ю. Мигрень. Патогенез, клиника, фармакотерапия: руководство для врачей. М.: МЕДпресс-информ, 2011. 256 с. [Amelin A. V., Ignatov Yu. D., Skoromets A. A., Sokolov A. Yu. Migraine. Pathogenesis, clinical picture, pharmacotherapy: handbook for physicians. Moscow: MEDpress-inform, 2011. 256 p. (In Russ.)].

33. First M. B., Spitzer R. L., Gibbon M., Williams J. B. Structured Clinical Interview for DSM- IV® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. Arlington, VA: American Psychiatric Publ., 2012.

34. Peng K. P., Wang S. J. Migraine diagnosis: screening items, instruments, and scales. Acta Anaesthesiol Taiwan 2012;50(2):69–73. DOI: 10.1016/j.aat.2012.05.002. PMID: 22769861.

35. Bagley C. L., Rendas-Baum R., Maglinte G. A. et al. Validating Migraine- Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache 2012;52(3):409–21. DOI: 10.1111/j.1526-4610.2011.01997.x. PMID: 21929662.